Susan Wyllie
Career
Upon graduation, Wyllie joined the University of North Carolina at Chapel Hill , as a postdoctoral researcher under Jane E. Raulston. She continued researching into Chlamydia . In 2001, she returned to Scotland and joined the University of Dundee , as a senior research associate under Alan Fairlamb . Wyllie researched on drug mechanism of action in Leishmania .
In 2015, Wyllie established the Mode of Action Group, a research group under the Wellcome Centre for Anti-Infectives Research. The group conducts studies to discover new drugs for chemically validated drug targets. In 2019, Wyllie became a principal investigator.
In 2024, she was appointed the professor of biochemical pharmacology. In 2026, Wyllie was elected a Fellow of the Royal Society of Edinburgh , in the discipline of biomedical and cognitive sciences.
Research
Wyllie's research is on kinetoplastid biology and parasitology . In February 2012, Wyllie was part of a team that identified fexinidazole as a treatment for Leishmaniasis . In recognition of her research, she was awarded the C. A. Wright Memorial Medal by the British Society for Parasitology .
To date, Wyllie has authored or co-authored more than 100 publications, and her research group has contributed to the development of five clinical drug candidates.
Selected publications
Wyllie, Susan; Cunningham, Mark L.; Fairlamb, Alan H. (13 July 2004). "Dual Action of Antimonial Drugs on Thiol Redox Metabolism in the Human Pathogen Leishmania donovani" . Journal of Biological Chemistry . 279 (38): 39925– 39932. doi :10.1074/jbc.M405635200 . eISSN 1083-351X . ISSN 0021-9258 . LCCN 06046735 . OCLC 54114375 . PMID 15252045 . CODEN JBCHA3 .
Wyllie, Susan; Patterson, Stephen; Stojanovski, Laste; Simeons, Frederick R. C.; Norval, Suzanne; Kime, Robert; Read, Kevin D.; Fairlamb, Alan H. (1 February 2012). "The Anti-Trypanosome Drug Fexinidazole Shows Potential for Treating Visceral Leishmaniasis" . Science Translational Medicine . 4 (119): 119re1. doi :10.1126/scitranslmed.3003326 . eISSN 1946-6242 . ISSN 1946-6234 . PMC 3457684 . PMID 22301556 .
Patterson, Stephen; Wyllie, Susan (26 April 2014). "Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects" . Trends in Parasitology . 30 (6): 289– 298. doi :10.1016/j.pt.2014.04.003 . PMC 4045206 . PMID 24776300 .
Wyllie, Susan; Brand, Stephen; Thomas, Michael; De Rycker, Manu; Chung, Chun-wa; Pena, Imanol; Bingham, Ryan P.; Bueren-Calabuig, Juan A.; Cantizani, Juan; Cebrian, David; Craggs, Peter D.; Ferguson, Liam; Goswami, Panchali; Hobrath, Judith; Howe, Jonathan (7 May 2019). "Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition" . Proceedings of the National Academy of Sciences . 116 (19): 9318– 9323. Bibcode :2019PNAS..116.9318W . doi :10.1073/pnas.1820175116 . eISSN 1091-6490 . ISSN 0027-8424 . JSTOR 00278424 . LCCN 16010069 . OCLC 43473694 . PMC 6511062 . PMID 30962368 .
De Rycker, Manu; Wyllie, Susan; Horn, David ; Read, Kevin D.; Gilbert, Ian H. (22 August 2022). "Anti-trypanosomatid drug discovery: progress and challenges" . Nature Reviews Microbiology . 21 (1): 35– 50. doi :10.1038/s41579-022-00777-y . eISSN 1740-1534 . ISSN 1740-1526 . LCCN 2009252829 . OCLC 780556277 . PMC 9395782 . PMID 35995950 . CODEN NRMACK .
References
1 2 3 4 "Getting to Know - Susan Wyllie" . Wellcome Centre for Anti-Infectives Research, University of Dundee . 27 August 2020. Retrieved 26 October 2026 .
↑ Wyllie, Susan (1998). Structural and functional characterisation of the major outer membrane protein of Chlamydia Psittaci (PhD thesis). University of Edinburgh . hdl :1842/22762 . Retrieved 26 October 2026 .
↑ "Leading academics awarded top honour". The Courier . 10 April 2026. Factiva COURIR0020260410em4a0001s .
1 2 "Professor Susan Wyllie" . Royal Society of Edinburgh . Retrieved 26 October 2026 .
↑ "Mode of Action Group" . Mode of Action Group . 5 April 2019. Retrieved 26 October 2026 .
↑ "Dr Susan Wyllie becomes Principal Investigator" . University of Dundee . 25 July 2019. Retrieved 26 October 2026 .
1 2 "Susan Wyllie awarded C.A. Wright Memorial Medal" . University of Dundee . 17 April 2023. Retrieved 26 October 2026 .
1 2 "Dundee academics elected Fellows of the RSE" . University of Dundee . Retrieved 26 October 2026 .
1 2 "People" . Mode of Action Group . 25 February 2019. Retrieved 26 October 2026 .
↑ "Professor Susan Wyllie" . University of Dundee . Retrieved 26 October 2026 .
↑ Wyllie, Susan; Patterson, Stephen; Stojanovski, Laste; Simeons, Frederick R. C.; Norval, Suzanne; Kime, Robert; Read, Kevin D.; Fairlamb, Alan H. (1 February 2012). "The Anti-Trypanosome Drug Fexinidazole Shows Potential for Treating Visceral Leishmaniasis" . Science Translational Medicine . 4 (119): 119re1. doi :10.1126/scitranslmed.3003326 . eISSN 1946-6242 . ISSN 1946-6234 . PMC 3457684 . PMID 22301556 .
↑ "Visceral Leishmaniasis; Potential new treatment identified for leishmaniasis". VerticalNews . Factiva JOUIND0020120217e82l00021 .
↑ "Susan Wyllie" . University of Dundee . Retrieved 26 October 2026 .